NY Times
DECEMBER 25, 2020
The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.
Outsourcing Pharma
DECEMBER 23, 2020
The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 23, 2020
NHS leaders have written to the UK prime minister urging him to extend the Brexit transition period by a month to avoid plunging the healthcare service into chaos on 1 January. The letter, published today by the NHS Confederation – a membership organisation representing NHS leaders from all parts of the health service, outlines concerns about the impact a no-deal outcome will have on delivering care to patients amid winter pressures and a rapid rise in COVID-19 infections. “The failu
Pharma Times
DECEMBER 22, 2020
Rekambys plus Vocabria authorised to treat HIV-1 infections in adults who are virologically suppressed
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
NY Times
DECEMBER 22, 2020
The 160-page civil complaint alleges that the retail giant knew that its system for detecting illegitimate prescriptions was inadequate.
Outsourcing Pharma
DECEMBER 22, 2020
A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
DECEMBER 22, 2020
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
NY Times
DECEMBER 25, 2020
The clinical trial in Turkey was much smaller than those of other major vaccine candidates, making the researchers’ claims for it less certain.
Outsourcing Pharma
DECEMBER 23, 2020
Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.
pharmaphorum
DECEMBER 21, 2020
2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. That said, there were still some interesting moves indicating new directions of travel for big pharma players – with most deals focused on specific drugs from biotechs, particularly in cancer (though we did get rumours of an AstraZeneca-Gilead merger , which would have been the
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
DECEMBER 21, 2020
EGFR-TKI approved in the US for early non-small cell lung cancer
NY Times
DECEMBER 21, 2020
Christie Smythe helped break the story of Mr. Shkreli’s arrest in 2015. Then she “started to fall for him,” she said, and quit her job at Bloomberg News.
Outsourcing Pharma
DECEMBER 21, 2020
A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.
pharmaphorum
DECEMBER 24, 2020
Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, any definitive ‘coming of age’ moment for the sector was unlikely. But that was before the first reports emerged of a highly contagious coronavirus and 2020 will be forever associated with COVID-19 and the global devastation and disruption it has wrought.
Pharma Times
DECEMBER 23, 2020
Oral solution approved to treat seizures associated with Dravet syndrome
NY Times
DECEMBER 23, 2020
Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.
Outsourcing Pharma
DECEMBER 22, 2020
A new survey from the supply-chain analysis company revals inefficiencies, inaccurate data and other flaws can be costly in terms of revenue, reputation and patient lives.
pharmaphorum
DECEMBER 24, 2020
Just a few weeks after its EU approval for heart failure, AstraZeneca’s Forxiga has been backed by NICE for this use by the NHS in England and Wales. Forxiga (dapagliflozin) – originally developed as a type 2 diabetes drug – is the first SGLT2 inhibitor to be approved for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults with and without diabetes.
Pharma Times
DECEMBER 23, 2020
REACH-CDM study was based on results of positive phase II data
NY Times
DECEMBER 23, 2020
There are already signs that the rollout will be messy, confusing and chaotic.
Outsourcing Pharma
DECEMBER 21, 2020
The pharma firm will lend support to Aqemiaâs high-tech drug discovery tools in order to work on discovery and development of therapies for the virus.
pharmaphorum
DECEMBER 23, 2020
French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic disorders. It’s a major change of direction for Boston-based Agios, which has been concentrating on the oncology market since its inception in 2008, bringing the Bristol Myers Squibb-partnered Tibsovo (ivosidenib) for IDH1-mutant acute myeloid leukaemia to the US market.
Pharma Times
DECEMBER 21, 2020
Treatment demonstrated non-inferior visual acuity gains compared to Regeneron's Eylea
Drug Patent Watch
DECEMBER 24, 2020
Annual Drug Patent Expirations for ALLEGRA-D+24+HOUR+ALLERGY+AND+CONGESTION Allegra-d 24 Hour Allergy And Congestion is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from…. The post New patent expiration for Sanofi Aventis drug ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Mirror
DECEMBER 23, 2020
Davis, CA: Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured $3.3 million in a seed round of funding, and is planning another round of funding for Spring 2021. The Spring 2021 Round of funding will boost BSI’s proven ability to discover and develop novel botanical products that are sustainable, highly consistent and cost effective.
pharmaphorum
DECEMBER 21, 2020
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and who is behind them, asks Richard Staines. A year ago, the names Moderna and BioNTech were known mainly to those who followed biotech and pharma dealings. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against t
Pharma Times
DECEMBER 21, 2020
Drug becomes first treatment for peanut allergy in the EU
Drug Patent Watch
DECEMBER 23, 2020
Annual Drug Patent Expirations for HETLIOZ Hetlioz is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are thirteen…. The post New patent for Vanda Pharms drug HETLIOZ appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Mirror
DECEMBER 23, 2020
During the last couple of years, medical software has gained a lot of momentum. It’s crucial for monitoring the health of patients, and it’s one of the best ways to put human ingenuity to use. The market for this niche is getting bigger, and it’s going to cross 30 billion dollars soon. Managers and local clinics need to know about all the benefits of using these kinds of programs.
pharmaphorum
DECEMBER 23, 2020
It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. But there was some considerable progress in other fields of medicine even though research efforts were diverted away, reports Richard Staines. The American Society of Clinical Oncology (ASCO) annual conference was one of the highlights of the year in cancer research and the fact it was held virtually did not distract from some stunni
Pharma Times
DECEMBER 23, 2020
Submission supported by results from phase II CodeBreaK 100 study
Drug Patent Watch
DECEMBER 23, 2020
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-two patents protecting…. The post New patent for NOVO drug OZEMPIC appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Marketing Network
DECEMBER 21, 2020
Stephen Towers, PhD is a leader in medical communications and healthcare marketing, with extensive experience in developing promotional medical education programs and medical affairs initiatives across numerous therapeutic areas and on behalf of diverse US healthcare organizations, from large pharmaceutical companies to smaller biotechs. As VP at Chameleon Communications (part of Omnicom Health Group), he leverages his scientific acumen and pharmaceutical expertise to create impactful scientific
pharmaphorum
DECEMBER 21, 2020
More than 1,000 NHS patients have booked flu vaccinations using a virtual assistant as part of a pilot project in the south east of England. The pilot project, run in collaboration with GP practices in Buckinghamshire, Brent, and Greenwich, involved patients using the Ask NHS app, which is already used by more than 375,000 patients. Patients in the pilot used the app developed by Sensely to self-check eligibility and quickly make appointments for flu jabs.
Pharma Times
DECEMBER 22, 2020
Follows positive opinion issued by EMA's CHMP
Expert insights. Personalized for you.
145 
Let's personalize your content